RESUMEN
BACKGROUND AIMS: Skeletal muscle regeneration after severe damage is reliant on local stem cell proliferation and differentiation, processes that are tightly regulated by macrophages. Peripheral artery disease is a globally prevalent cardiovascular disease affecting millions of people. Progression of the disease leads to intermittent claudication, subsequent critical limb ischemia and muscle injury. Tissue-derived and ex vivo-expanded mesenchymal stromal cells (MSCs) for skeletal muscle regeneration have been studied, but pre-clinical and clinical results have not been consistent. As a result, the potential therapeutic efficacy and associated repair mechanisms of MSCs remain unclear. Numerous studies have demonstrated the vulnerability of delivered MSCs, with a precipitous drop in cell viability upon transplantation. This has prompted investigation into the therapeutic benefit of apoptotic cells, microvesicles, exosomes and soluble signals that are released upon cell death. METHODS: In this study, we characterized various components produced by MSCs after cell death induction under different conditions. We discovered anti-inflammatory and pro-regenerative effects produced by cell components following a freeze and thaw (F&T) process on macrophage polarization in vitro. We further investigated the underlying mechanisms of macrophage polarization by those components resulting from severe cell death induction. RESULTS: We found potent therapeutic effects from F&T-induced cell debris are dependent on the externalization of phosphatidylserine on the plasma membrane. In contrast, effects from the supernatant of F&T-induced cell death primarily depends on the released protein content. We then applied the F&T-induced cell supernatant to an animal model of peripheral artery disease to treat muscle injury caused by severe ischemia. Treatment with the F&T supernatant but not the vulnerable MSCs resulted in significantly improved recovery of muscle function, blood flow and morphology and inflammation resolution in the affected muscles 2 weeks after injury. CONCLUSIONS: This study validates the therapeutic potential of F&T-induced supernatant obviating the need for a viable population from vulnerable MSCs to treat injury, thus providing a roadmap for cell-free therapeutic approaches for tissue regeneration.
Asunto(s)
Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas , Enfermedad Arterial Periférica , Animales , Inflamación/terapia , Inflamación/metabolismo , Isquemia/terapia , Enfermedad Arterial Periférica/terapia , Músculos , Trasplante de Células Madre Mesenquimatosas/métodosRESUMEN
Muscle development is controlled by the balance between muscle protein synthesis and protein degradation. Protein supplementation has been widely known to enhance muscle protein synthesis, and carbohydrate supplementation may attenuate protein degradation. The purpose of this study was to compare the effects of whey protein plus carbohydrate (CP), whey protein (WP), and placebo (PLA) supplements on resistance training adaptations. Two-month old rats were trained by ladder climbing every 3 days for 8 weeks. PLA, WP, or CP was given immediately after each exercise session. Non-exercise rats were used as a sedentary control (SED). Total body composition was assessed and blood samples were collected before, middle, and end of training. The flexor hallucis longus (FHL) was excised 24â¯h after the last exercise session. Following training, maximal carrying capacity was significantly greater in CP than PLA and WP. This improved training performance in CP paralleled an increase in total muscle and myofibrillar protein content. Muscle and fiber cross sectional areas (CSA) were significantly increased by exercise training, with a concomitant increase in myonuclear domain. CP significantly elevated IGF-1 protein expression over SED, but there were no significant differences in myostatin, Pax7, MyoD, or myogenin across treatment groups. There was also no difference in the number of total nuclei in each fiber CSA among groups. Corticosterone levels were significantly elevated in PLA and WP over 8 weeks of training, whereas this change in corticosterone over time was not observed in the CP group. The results suggest that the greater improvement of maximal caring capacity for CP compared with PLA and WP was associated with a greater increase in myofibrillar protein content. Satellite cell activation did not appear to contribute to the observed gains in muscle hypertrophy and strength.
RESUMEN
OBJECTIVE: Peripheral arterial disease can cause not only ischemia but also skeletal muscle damage. It has been known that macrophages (MPs) play an important role in coordinating muscle repair; however, phenotype transition of monocyte-MP in ischemic muscle has not been well defined. Hence, the purpose of this study was to examine the temporal recruitment of MPs and to explore their therapeutic effect on ischemic muscle regeneration. METHODS: Unilateral femoral artery excision was performed on C57BL/6 mice. Myeloid cells were isolated from the ischemic muscles, characterized using flow cytometry. Bone marrow-derived MPs were injected (2 × 106 cells) into the ischemic gastrocnemius muscle 24 hours after injury. Blood flow recovery was measured using laser speckle imaging. Functional outcome was evaluated by assessing the contractile force of ischemic muscles. Histologic analysis included quantification of myofiber size, collagen deposition, number of inflammatory and MyoD-expressing cells, and capillary density. RESULTS: Neutrophils and inflammatory monocytes-MPs were present at day 1 after injury. The mature MPs then remained elevated as the dominant population from day 5 to day 21 with the observation of regenerating fibers. Functional measurements revealed that the force production was significantly enhanced after treatment with proinflammatory M1 MPs (94.9% vs 77.9%; P < .05), and this was consistent with increased myofiber size, capillary- fiber ratio, and perfusion (78.6% vs 39.9%; P < .05). Moreover, the percentage of MyoD-expressing nuclei was significantly higher at day 4, indicating that M1 MPs may hasten muscle repair. Whereas early delivery of anti-inflammatory M2 MPs improved myofiber size, this was accompanied by persistent fibrosis suggesting ongoing tissue remodeling, and lower force production was observed. CONCLUSIONS: We demonstrated the dynamics of myeloid cells in skeletal muscle after ischemic insult, and the administration of exogenous M1 MPs in a temporally coordinated manner successfully improved angiogenesis and skeletal muscle regeneration. Our results suggested that cell therapy using MPs may be a promising adjunctive therapeutic approach for peripheral arterial disease.
Asunto(s)
Tratamiento Basado en Trasplante de Células y Tejidos/métodos , Miembro Posterior/irrigación sanguínea , Isquemia/terapia , Macrófagos/trasplante , Músculo Esquelético/patología , Animales , Velocidad del Flujo Sanguíneo , Modelos Animales de Enfermedad , Femenino , Citometría de Flujo , Isquemia/patología , Isquemia/fisiopatología , Ratones , Ratones Endogámicos C57BL , Contracción Muscular , Músculo Esquelético/fisiopatologíaRESUMEN
The objective of the study was to investigate whether co-ingestion of carbohydrate and protein as compared with protein alone augments muscle protein synthesis (MPS) during early exercise recovery. Two months old rats performed 10 repetitions of ladder climbing with 75% of body weight attached to their tails. Placebo (PLA), whey protein (WP), or whey protein plus carbohydrate (CP) was then given to rats by gavage. An additional group of sedentary rats (SED) was used as controls. Blood samples were collected immediately and at either 1 or 2 h after exercise. The flexor hallucis longus muscle was excised at 1 or 2 h post exercise for analysis of MPS and related signaling proteins. MPS was significantly increased by CP compared with PLA (p<0.05), and approached significance compared with WP at 1 h post exercise (p = 0.08). CP yielded a greater phosphorylation of mTOR compared with SED and PLA at 1 h post exercise and SED and WP at 2 h post exercise. CP also increased phosphorylation of p70S6K compared with SED at 1 and 2 h post exercise. 4E-BP1 phosphorylation was inhibited by PLA at 1 h but elevated by WP and CP at 2 h post exercise relative to SED. The phosphorylation of AMPK was elevated by exercise at 1 h post exercise, and this elevated level was sustained only in the WP group at 2 h. The phosphorylation of Akt, GSK3, and eIF2Bε were unchanged by treatments. Plasma insulin was transiently increased by CP at 1 h post exercise. In conclusion, post-exercise CP supplementation increases MPS post exercise relative to PLA and possibly WP, which may have been mediated by greater activation of the mTOR signaling pathway.
Asunto(s)
Carbohidratos/administración & dosificación , Proteínas Musculares/biosíntesis , Condicionamiento Físico Animal , Proteína de Suero de Leche/administración & dosificación , Animales , Glucemia/metabolismo , Proteínas Musculares/metabolismo , Ratas , Transducción de SeñalRESUMEN
AIM: Progressive ischemia due to peripheral artery disease causes muscle damage and reduced strength of the lower extremities. Autologous cell therapy is an attractive treatment to restore perfusion and improve muscle function. Adipose-derived stem cells (ASCs) have therapeutic potential in tissue repair, including polarizing effects on macrophages (MPs). MATERIALS & METHODS: Co-culture systems of ASCs and MPs were analyzed for gene and protein expression modifications in ASC-conditioned MPs. Co-transplantation of MPs/ASCs in vivo led to improved skeletal muscle regeneration in a mouse model of peripheral artery disease. RESULTS: ASCs/MPs therapy restored muscle function, increased perfusion and reduced inflammatory infiltrate. CONCLUSION: Combined MPs/ASCs cell therapy is a promising approach to restore muscle function and stimulate local angiogenesis in the ischemic limb.
Asunto(s)
Tejido Adiposo/citología , Tratamiento Basado en Trasplante de Células y Tejidos , Isquemia/terapia , Macrófagos/citología , Músculo Esquelético/citología , Regeneración/fisiología , Células Madre/citología , Animales , Células Cultivadas , Técnicas de Cocultivo , Modelos Animales de Enfermedad , Femenino , Humanos , Ratones , Ratones Endogámicos C57BL , Músculo Esquelético/lesiones , Neovascularización Fisiológica , Enfermedad Arterial Periférica/terapia , Trasplante de Células MadreRESUMEN
The intent of the current study was to investigate the therapeutic contribution of MSCs to vascular regeneration and functional recovery of ischemic tissue. We used a rodent hind limb ischemia model and intramuscularly delivered MSCs within a PEGylated fibrin gel matrix. Within this model, we demonstrated that MSC therapy, when delivered in PEGylated fibrin, results in significantly higher mature blood vessel formation, which allows for greater functional recovery of skeletal muscle tissue as assessed using force production measurements. We observed initial signs of vascular repair at early time points when MSCs were delivered without PEGylated fibrin, but this did not persist or lead to recovery of the tissue in the long-term. Furthermore, animals which were treated with PEGylated fibrin alone exhibited a greater number of mature blood vessels, but they did not arterialize and did not show improvements in force production. These results demonstrate that revascularization of ischemic tissue may be a necessary but not sufficient step to complete functional repair of the injured tissue. This work has implications on stem cell therapies for ischemic diseases and also potentially on how such therapies are evaluated.
Asunto(s)
Fibrina/química , Geles/química , Isquemia/terapia , Trasplante de Células Madre Mesenquimatosas/métodos , Células Madre Mesenquimatosas/citología , Polietilenglicoles/química , Animales , Materiales Biocompatibles/química , Células Cultivadas , Miembro Posterior/irrigación sanguínea , Miembro Posterior/patología , Isquemia/patología , Neovascularización Fisiológica , Ratas , Ratas Endogámicas Lew , Andamios del Tejido/químicaRESUMEN
Skeletal muscle regeneration following acute injury is a multi-step process involving complex changes in tissue microenvironment. Macrophages (MPs) are one of the key cell types involved in orchestration and modulation of the repair process. Multiple studies highlight the essential role of MPs in the control of the myogenic program and inflammatory response during skeletal muscle regeneration. A variety of MP phenotypes have been identified and characterized in vitro as well as in vivo. As such, MPs hold great promise for cell-based therapies in the field of regenerative medicine. In this study we used bone-marrow derived in vitro LPS/IFN-y-induced M1 MPs to enhance functional muscle recovery after tourniquet-induced ischemia/reperfusion injury (TK-I/R). We detected a 15% improvement in specific tension and force normalized to mass after M1 (LPS/IFN-γ) MP transplantation 24 hours post-reperfusion. Interestingly, we found that M0 bone marrow-derived unpolarized MPs significantly impaired muscle function highlighting the complexity of temporally coordinated skeletal muscle regenerative program. Furthermore, we show that delivery of M1 (LPS/IFN-γ) MPs early in regeneration accelerates myofiber repair, decreases fibrotic tissue deposition and increases whole muscle IGF-I expression.
Asunto(s)
Macrófagos/trasplante , Músculo Esquelético/lesiones , Músculo Esquelético/fisiopatología , Animales , Peso Corporal/efectos de los fármacos , Células de la Médula Ósea/citología , Polaridad Celular/efectos de los fármacos , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Inflamación/patología , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , Interferón gamma/farmacología , Antígenos Comunes de Leucocito/metabolismo , Lipopolisacáridos/farmacología , Macrófagos/citología , Macrófagos/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Fibras Musculares Esqueléticas/efectos de los fármacos , Fibras Musculares Esqueléticas/patología , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Fenotipo , Reacción en Cadena en Tiempo Real de la Polimerasa , Daño por Reperfusión/patología , Coloración y Etiquetado , Cicatrización de Heridas/efectos de los fármacosRESUMEN
Therapeutic delivery of regeneration-promoting biological factors directly to the site of injury has demonstrated its efficacy in various injury models. Several reports describe improved tissue regeneration following local injection of tissue specific growth factors, cytokines and chemokines. Evidence exists that combined cytokine/growth factor treatment is superior for optimizing tissue repair by targeting different aspects of the regeneration response. The purpose of this study was to evaluate the therapeutic potential of the controlled delivery of stromal cell-derived factor-1alpha (SDF-1α) alone or in combination with insulin-like growth factor-I (SDF-1α/IGF-I) for the treatment of tourniquet-induced ischemia/reperfusion injury (TK-I/R) of skeletal muscle. We hypothesized that SDF-1α will promote sustained stem cell recruitment to the site of muscle injury, while IGF-I will induce progenitor cell differentiation to effectively restore muscle contractile function after TK-I/R injury while concurrently reducing apoptosis. Utilizing a novel poly-ethylene glycol PEGylated fibrin gel matrix (PEG-Fib), we incorporated SDF-1α alone (PEG-Fib/SDF-1α) or in combination with IGF-I (PEG-Fib/SDF-1α/IGF-I) for controlled release at the site of acute muscle injury. Despite enhanced cell recruitment and revascularization of the regenerating muscle after SDF-1α treatment, functional analysis showed no benefit from PEG-Fib/SDF-1α therapy, while dual delivery of PEG-Fib/SDF-1α/IGF-I resulted in IGF-I-mediated improvement of maximal force recovery and SDF-1α-driven in vivo neovasculogenesis. Histological data supported functional data, as well as highlighted the important differences in the regeneration process among treatment groups. This study provides evidence that while revascularization may be necessary for maximizing muscle force recovery, without modulation of other effects of inflammation it is insufficient.
Asunto(s)
Diferenciación Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Quimiocina CXCL12/química , Fibrina/química , Factor I del Crecimiento Similar a la Insulina/administración & dosificación , Músculo Esquelético/efectos de los fármacos , Receptores CXCR4/química , Recuperación de la Función/efectos de los fármacos , Regeneración/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Quimiocina CXCL12/farmacocinética , Quimiocina CXCL12/farmacología , Sistemas de Liberación de Medicamentos , Fibrina/farmacología , Humanos , Factor I del Crecimiento Similar a la Insulina/química , Receptores CXCR4/metabolismoRESUMEN
The presence of macrophages (MPs) is essential for skeletal muscle to properly regenerate following injury. The aim of this study was the evaluation of MP profiles and their importance in skeletal muscle recovering from tourniquet-induced ischemia-reperfusion (I/R). Using flow cytometry, we identified two distinct CD11b(+) MP populations that differ in expression of the surface markers Ly-6C and F4/80. These populations are prominent at 3 and 5 days of reperfusion and molecularly correspond to inflammatory and anti-inflammatory MP phenotypes. Sorted MP populations demonstrated high levels of IGF-I expression, and whole muscle post-I/R IGF-I expression strongly correlates with F4/80 expression. This suggests MPs largely influence postinjury IGF-I upregulation. We additionally demonstrate that direct intramuscular injection of FACS-isolated CD11b(+)Ly-6C(lo)F4/80(hi) MPs improves the functional and histological recovery of I/R-affected muscle. Taken together, these data further support the substantial influence of the innate immune system on muscle regeneration and suggest MP-focused therapeutic approaches may greatly facilitate skeletal muscle recovery from substantial injury.
Asunto(s)
Macrófagos/fisiología , Músculo Esquelético/lesiones , Recuperación de la Función/inmunología , Daño por Reperfusión/inmunología , Animales , Antígenos Ly/metabolismo , Antígeno CD11b/metabolismo , Masculino , Ratones Endogámicos C57BL , Músculo Esquelético/irrigación sanguíneaRESUMEN
In lower or simple species, such as worms and flies, disruption of the insulin-like growth factor (IGF)-1 and the insulin signaling pathways has been shown to increase lifespan. In rodents, however, growth hormone (GH) regulates IGF-1 levels in serum and tissues and can modulate lifespan via/or independent of IGF-1. Rodent models, where the GH/IGF-1 axis was ablated congenitally, show increased lifespan. However, in contrast to rodents where serum IGF-1 levels are high throughout life, in humans, serum IGF-1 peaks during puberty and declines thereafter during aging. Thus, animal models with congenital disruption of the GH/IGF-1 axis are unable to clearly distinguish between developmental and age-related effects of GH/IGF-1 on health. To overcome this caveat, we developed an inducible liver IGF-1-deficient (iLID) mouse that allows temporal control of serum IGF-1. Deletion of liver Igf-1 gene at one year of age reduced serum IGF-1 by 70% and dramatically impaired health span of the iLID mice. Reductions in serum IGF-1 were coupled with increased GH levels and increased basal STAT5B phosphorylation in livers of iLID mice. These changes were associated with increased liver weight, increased liver inflammation, increased oxidative stress in liver and muscle, and increased incidence of hepatic tumors. Lastly, despite elevations in serum GH, low levels of serum IGF-1 from 1 year of age compromised skeletal integrity and accelerated bone loss. We conclude that an intact GH/IGF-1 axis is essential to maintain health span and that elevated GH, even late in life, associates with increased pathology.
Asunto(s)
Envejecimiento/metabolismo , Factor I del Crecimiento Similar a la Insulina/deficiencia , Envejecimiento/sangre , Animales , Femenino , Factor I del Crecimiento Similar a la Insulina/metabolismo , Masculino , Ratones , Modelos Animales , Estrés Oxidativo/fisiologíaRESUMEN
Ischemia/reperfusion (I/R) injury is a considerable insult to skeletal muscle, often resulting in prolonged functional deficits. The purpose of the current study was to evaluate the controlled release of the pro-regenerative growth factor, insulin-like growth factor-I (IGF-I), from a biodegradable polyethylene glycol (PEG)ylated fibrin gel matrix and the subsequent recovery of skeletal muscle from I/R. To accomplish this, the hind limbs of male Sprague-Dawley rats were subjected to 2-h tourniquet-induced I/R then treated with saline, bolus IGF-I (bIGF), PEGylated fibrin gel (PEG-Fib), or IGF-I conjugated PEGylated fibrin gel (PEG-Fib-IGF). Functional and histological evaluations were performed following 14 days of reperfusion, and muscles from 4-day reperfusion animals were analyzed by Western blotting and histological assessments. There was no difference in functional recovery between saline, bIGF, or PEG-Fib groups. However, PEG-Fib-IGF treatment resulted in significant improvement of muscle function and structure, as observed histologically. Activation of the PI3K/Akt pathway was significantly elevated in PEG-Fib-IGF muscles, compared to PEG-Fib treatment, at 4 days of reperfusion, suggesting involvement of the pathway PI3K/Akt as a mediator of the improved function. Surprisingly, myoblast activity was not evident as a result of PEG-Fib-IGF treatment. Taken together, these data give evidence for a protective role for the delivered IGF. These results indicate that PEG-Fib-IGF is a viable therapeutic technique in the treatment of skeletal muscle I/R injury.
Asunto(s)
Factor I del Crecimiento Similar a la Insulina/uso terapéutico , Músculo Esquelético/irrigación sanguínea , Daño por Reperfusión/tratamiento farmacológico , Implantes Absorbibles , Animales , Portadores de Fármacos , Evaluación Preclínica de Medicamentos , Implantes de Medicamentos , Fibrina/administración & dosificación , Fibrina/análogos & derivados , Geles , Miembro Posterior/irrigación sanguínea , Inyecciones Intramusculares , Factor I del Crecimiento Similar a la Insulina/administración & dosificación , Masculino , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Fosfatidilinositol 3-Quinasas/fisiología , Polietilenglicoles/administración & dosificación , Proteínas Proto-Oncogénicas c-akt/fisiología , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/patología , Transducción de Señal , TorniquetesRESUMEN
With the advancement of age, skeletal muscle undergoes a progressive decline in mass, function, and regenerative capacity. Previously, our laboratory has reported an age-reduction in recovery and local induction of IGF-I gene expression with age following tourniquet (TK)-induced skeletal muscle ischemia/reperfusion (I/R). In this study, young (6 mo) and old (24-28 mo) mice were subjected to 2h of TK-induced ischemia of the hindlimb followed by 1, 3, 5, or 7 days of reperfusion. Real time-PCR analysis revealed clear age-related reductions and temporal alterations in the expression of IGF-I and individual IGF-I Ea and Eb splice variants. ELISA verified a reduction of IGF-I peptide with age following 7 day recovery from TK. Western blotting showed that the phosphorylation of Akt, mTOR, and FoxO3, all indicators of anabolic activity, were reduced in the muscles of old mice. These data indicate that an age-related impairment of IGF-I expression and intracellular signaling does exist following injury, and potentially has a role in the impaired recovery of skeletal muscle with age.
Asunto(s)
Envejecimiento/genética , Factor I del Crecimiento Similar a la Insulina/genética , Músculo Esquelético/lesiones , Daño por Reperfusión/genética , Envejecimiento/metabolismo , Envejecimiento/patología , Empalme Alternativo , Animales , Secuencia de Bases , Cartilla de ADN/genética , Proteína Forkhead Box O3 , Factores de Transcripción Forkhead/metabolismo , Expresión Génica , Factor I del Crecimiento Similar a la Insulina/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Músculo Esquelético/irrigación sanguínea , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Sarcopenia/genética , Sarcopenia/metabolismo , Transducción de Señal , Serina-Treonina Quinasas TOR/metabolismoRESUMEN
Skeletal muscle injury resulting in tissue loss poses unique challenges for surgical repair. Despite the regenerative potential of skeletal muscle, if a significant amount of tissue is lost, skeletal myofibers will not grow to fill the injured area completely. Prior work in our lab has shown the potential to fill the void with an extracellular matrix (ECM) scaffold, resulting in restoration of morphology, but not functional recovery. To improve the functional outcome of the injured muscle, a muscle-derived ECM was implanted into a 1 x 1 cm(2), full-thickness defect in the lateral gastrocnemius (LGAS) of Lewis rats. Seven days later, bone-marrow-derived mesenchymal stem cells (MSCs) were injected directly into the implanted ECM. Partial functional recovery occurred over the course of 42 days when the LGAS was repaired with an MSC-seeded ECM producing 85.4 +/- 3.6% of the contralateral LGAS. This was significantly higher than earlier recovery time points (p < 0.05). The specific tension returned to 94 +/- 9% of the contralateral limb. The implanted MSC-seeded ECM had more blood vessels and regenerating skeletal myofibers than the ECM without cells (p < 0.05). The data suggest that the repair of a skeletal muscle defect injury by the implantation of a muscle-derived ECM seeded with MSCs can improve functional recovery after 42 days.
Asunto(s)
Células de la Médula Ósea/citología , Matriz Extracelular/química , Trasplante de Células Madre Mesenquimatosas/métodos , Músculo Esquelético/citología , Músculo Esquelético/lesiones , Músculo Esquelético/cirugía , Ingeniería de Tejidos/métodos , Animales , Desmina/metabolismo , Inmunohistoquímica , Masculino , Miogenina/metabolismo , RatasRESUMEN
Accurate assessments of aerobic capacity are essential to ensuring the health and well-being of firefighters, given their arduous and stressful working conditions. The use of a submaximal protocol, if proven accurate, addresses concerns such as administrative cost, time, and ease of test performance. The purposes of this study were to develop and validate graded submaximal and maximal stairmill protocols and to develop accurate maximal and submaximal equations to predict peak VO2 using both the stairmill and Gerkin treadmill protocols. Fifty-four subjects, men (36.3 +/- 5.6 years) and women (36.4 +/- 6.3 years), performed maximal graded exercise tests using both the stairmill and Gerkin treadmill protocols. Significant predictors of peak VO2 included body mass index, time to completion for maximal protocols, and time to 85% of predicted maximal heart rate for submaximal protocols. Maximal prediction equations were more accurate on both the treadmill (R = 0.654, standard error of the estimate [SEE] = 3.73 ml x kg(-1) x min(-1)) and stairmill (R = 0.816, SEE = 2.89 ml x kg(-1) x min(-1)) than developed submaximal prediction equations for both the treadmill (R = 0.325, SEE = 5.20 ml x kg(-1) x min(-1)) and stairmill (R = 0.480, SEE = 4.85 ml x kg(-1) x min(-1)). Both of the newly developed submaximal prediction equations more accurately predict peak VO2 than the current Gerkin equation. In summary, we support the use of both the stairmill and treadmill as a means for aerobic assessment in this population. The use of the developed submaximal prediction equations should lead to a reduced cost and time of assessment; however, direct measurement of maximal oxygen consumption remains the better alternative.
Asunto(s)
Prueba de Esfuerzo/métodos , Ejercicio Físico/fisiología , Aptitud Física/fisiología , Adulto , Presión Sanguínea/fisiología , Índice de Masa Corporal , Femenino , Frecuencia Cardíaca/fisiología , Humanos , Masculino , Consumo de Oxígeno/fisiología , Valor Predictivo de las Pruebas , Factores SexualesRESUMEN
The loss of a portion of skeletal muscle poses a unique challenge for the normal regeneration of muscle tissue. A transection injury with tissue loss will not heal due to the gap between muscle segments. A damage model was developed by removing a portion of the lateral gastrocnemius (GAS) of Sprague-Dawley rats. Maximal isometric, tetanic tension (P(o)) was measured after the removal of either a small defect (0.5 x 1.0 cm) or a large defect (1.0 x 1.0 cm) piece of the GAS. In situ P(o) immediately after creation of the defect was 88.3 +/- 2.0% of the nonoperated contralateral GAS force for small defect and 76.9 +/- 3.2% of control for large defect. No functional recovery occurred in either group over the course of 28 days. To enhance recovery, a homologous, decellularized, muscle extracellular matrix (ECM) was implanted into the 1 x 1 cm defect of the lateral GAS of Lewis rats. After 42 days, growth of blood vessels and myofibers into the ECM was apparent, but no restoration of P(o) occurred. These data demonstrate the ability of the ECM to support muscle and blood vessel regeneration, but full recovery of function does not occur after 42 days.
Asunto(s)
Músculo Esquelético/fisiología , Regeneración , Andamios del Tejido , Animales , Matriz Extracelular , Contracción Isométrica , Masculino , Músculo Esquelético/irrigación sanguínea , Músculo Esquelético/lesiones , Neovascularización Fisiológica , Ratas , Ratas Endogámicas Lew , Ratas Sprague-Dawley , Resistencia a la Tracción , Factores de Tiempo , Ingeniería de Tejidos/métodosRESUMEN
The involvement of circulating insulin-like growth factor-I (IGF-I) in the skeletal muscle response to resistance exercise is currently unclear. To address this, we utilized the liver IGF-I-deficient (LID) mouse model, in which the igf1 gene has been disrupted in the hepatocytes, resulting in ~80% reduction in serum IGF-I. Twelve- to 13-month-old male LID and control (L/L) mice were subjected to 16 weeks of resistance training. Resistance exercise resulted in equal strength gains in both L/L and LID mice. Basal IGF-I mRNA levels were greater in LID muscles than in L/L, and exercise increased IGF-I mRNA in quadriceps, gastrocnemius, and plantaris muscles. LID mice had elevated tyrosine phosphorylation of IGF-IR and Stat5b, the latter possibly reflective of increased serum GH. Tyrosine phosphorylation of IGF-IR was increased, while phospho-Stat5b was reduced after resistance training of both wild-type and LID mice. These data suggest that: 1) performance and recovery in response to resistance training is normal even when there is severe deficiency of circulating IGF-I; and 2) upregulation of local IGF-I may be involved in the compensatory growth of muscle that occurs in response to resistance training. Decreased levels of p-Stat5b in exercised mice suggests that the upregulation of local IGF-I gene expression in response to exercise may be GH-independent.
Asunto(s)
Factor I del Crecimiento Similar a la Insulina/deficiencia , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Condicionamiento Físico Animal/fisiología , Animales , Peso Corporal , Regulación de la Expresión Génica , Hipertrofia , Factor I del Crecimiento Similar a la Insulina/genética , Masculino , Ratones , Tamaño de los Órganos , Músculo Cuádriceps/metabolismo , Músculo Cuádriceps/patología , ARN Mensajero/genética , ARN Mensajero/metabolismoRESUMEN
This study investigated the effect of age on recovery of skeletal muscle from an ischemia-reperfusion (I/R)-induced injury. Young (6 mo old) and old (24-27 mo old) Sprague-Dawley rats underwent a 2-h bout of hindlimb ischemia induced by a pneumatic tourniquet (TK). The TK was released to allow reperfusion of the affected limb, and animals were divided into 7- and 14-day recovery groups. Maximum plantar flexor force production was assessed in both 7- and 14-day recovery groups of both ages, followed by histological evaluation. Subsequent analysis of IGF-I gene expression and intracellular signaling in 7-day recovery muscles was performed by RT-PCR and Western blotting, respectively. Old rats had significantly greater deficits in force production and exhibited more evidence of histological pathology than young at both 7 and 14 days postinjury. In addition, old rats demonstrated an attenuated upregulation of IGF-I mRNA and induction of proanabolic signaling compared with young in response to injury. We conclude that aged skeletal muscle exhibits more damage and/or defective regeneration following I/R and identify an age-associated decrease in local IGF-I responsiveness as a potential mechanism for this phenomenon.
Asunto(s)
Factor I del Crecimiento Similar a la Insulina/metabolismo , Fuerza Muscular , Músculo Esquelético/metabolismo , Músculo Esquelético/fisiopatología , Regeneración , Daño por Reperfusión/metabolismo , Daño por Reperfusión/fisiopatología , Factores de Edad , Animales , Modelos Animales de Enfermedad , Miembro Posterior , Factor I del Crecimiento Similar a la Insulina/genética , Masculino , Músculo Esquelético/irrigación sanguínea , Músculo Esquelético/patología , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Recuperación de la Función , Daño por Reperfusión/etiología , Daño por Reperfusión/genética , Transducción de Señal , Factores de Tiempo , Torniquetes/efectos adversosRESUMEN
INTRODUCTION: Maximal rowing power-velocity relationships that exhibit ascending and descending limbs and a local maximum have not been reported. Further, duty cycle (portion of the stroke occupied by the pull phase) is unconstrained during rowing and is known to influence average muscular power output. PURPOSE: Our purposes for conducting this study were to fully describe maximal short-term rowing force-velocity and power-velocity relationships. Within the context of those purposes, we also aimed to determine the apex of the power-velocity relationship and the influence of freely chosen duty cycle on stroke power. METHODS: Collegiate varsity male rowers (N = 11, 22.9 +/- 2.3 yr, 84.1 + 12.1 kg, 184 +/- 7 cm) performed five maximal rowing trials using an inertial load ergometer. For each stroke, we determined force and power averaged for the pull phase and the complete stroke, instantaneous peak force and power, average handle velocity for the pull phase, handle velocity at peak instantaneous force and power, pull time, recovery time, and freely chosen duty cycle. Force-velocity and power-velocity relationships were characterized using regression analyses, and optimal velocities were determined from the regression coefficients. RESULTS: Pull force-velocity (r2 = 0.99) and peak instantaneous force-velocity (r2 = 0.93) relationships were linear. Stroke power (r2 = 0.98), pull power (r2 = 0.99), and instantaneous peak power (r2 = 0.99) were quadratic, with apexes at 2.04, 3.25, and 3.43 m x s(-1), respectively. Maximum power values were 812 +/- 28 W (9.8 +/- 0.4 W x kg(-1)), 1995 +/- 67 W (23.9 +/- 0.7 W x kg(-1)), and 3481 +/- 112 W (41.9 +/- 1.3 W x kg(-1)) for stroke, pull, and instantaneous power, respectively. Freely chosen duty cycle decreased from 58 +/- 1% on the first stroke to 26 +/- 1% on the fifth stroke. CONCLUSIONS: These data characterized the maximal rowing force-velocity and power-velocity relationships and identified the optimal velocity for producing maximal rowing power. Differences in maximum pull and stroke power emphasized the importance of duty cycle.
Asunto(s)
Umbral Anaerobio/fisiología , Ergometría , Contracción Muscular/fisiología , Músculo Esquelético/fisiología , Esfuerzo Físico/fisiología , Deportes/fisiología , Adulto , Fenómenos Biomecánicos , Humanos , Masculino , Estudios Prospectivos , Factores de TiempoRESUMEN
Sarcopenia is the decline of muscle mass and strength with age. Sarcopenia leads to significant impairment in the ability to carry out normal daily function and thus there is a great need for interventions that will lead to muscle regeneration and repair in the aging population. Age-related sarcopenia in humans, characterized by loss of type I and type II muscle fibers and a decrease in fiber cross-sectional area primarily in type II fibers, can be attenuated by mechanical load on the muscle, which increases cross-sectional area of the remaining fibers, but does not restore fiber numbers characteristic of young muscle. Considerable evidence also implicates age-related declines in muscle insulin-like growth factor action in sarcopenia. IGF-I promotes myoblast proliferation, differentiation, and protein accretion in muscle through multiple signaling mechanisms, including the PI3-kinase, MAP kinase and calcineurin pathways. Exercise and injury induce increases in IGF-I, IGF-I receptors and IGF-I-activated signaling pathways. Although there is evidence that aging muscle retains the ability to synthesize IGF-I, there is also evidence that aging may be associated with attenuation of the ability of exercise to induce an isoform of IGF-I that promotes satellite cell proliferation. Moreover, aging muscle may be resistant to IGF-I, an effect that is reversed by exercise. However, it is clear that over-expression of IGF-I in muscle can protect against age-related sarcopenia.
Asunto(s)
Envejecimiento/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Músculo Esquelético/metabolismo , Atrofia Muscular/prevención & control , Educación y Entrenamiento Físico , Empalme Alternativo , Animales , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Humanos , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/farmacología , Músculo Esquelético/citología , Músculo Esquelético/efectos de los fármacos , Atrofia Muscular/metabolismo , Atrofia Muscular/patología , ARN Mensajero/metabolismo , TransfecciónRESUMEN
BACKGROUND: Cross-sectional studies reported that chronic resistance training is associated with arterial stiffening in men. These findings are in marked contrast to those found with aerobic exercise and may have important clinical relevance with regard to cardiovascular disease risk. However, the effect of resistance training on arterial stiffness has not been confirmed by interventional studies nor has this relation been investigated in women. METHODS: To determine whether a strength training program increases regional and central arterial stiffness in women, 23 healthy young women (29+/-1 years; mean+/-SD) participated in a high-intensity strength and power training program for 11 weeks. Ten other women (27+/-2 years) served as time controls. RESULTS: In the intervention group, one repetition maximal strength increased 12% to 17% (P<.0001), and leg fat-free mass (via DEXA) increased significantly. Brachial blood pressure (BP) and fasting plasma lipid and lipoprotein concentrations did not change across the 11 weeks. Carotid augmentation index, a measure of arterial wave reflection and arterial stiffness, increased from -8%+/-13% to 1%+/-18% (P<.05), and carotid-femoral pulse wave velocity increased (791+/-88 v 833+/-96 cm/sec; P<.05). There were no changes in femoral-ankle pulse wave velocity, a segmental measure of peripheral arterial stiffness. CONCLUSIONS: We concluded that a high-intensity resistance training program increases arterial stiffness and wave reflection in young healthy women. Our present interventional results are consistent with the previous cross-sectional studies in men in which high-intensity strength training is associated with arterial stiffening.